Immunologist confirms that the use of a third dose of Anticovid should be analyzed

A study by the Department of Pediatrics of the Medical Faculty of the Universidad Mayor de San Andrés (UMSA) in La Paz suggested using the anticovid vaccine in the age group of 12 to 18 year olds.

“We recommend vaccination against Covid-19 for the age group between 12 and 18 years and believe that the need for vaccination against Covid-19 in children under 12 years of age with comorbid situations should be addressed,” says part of the test report.

The study shows that at the start of the pandemic, WHO traced 2% of Covid-19 cases to people under the age of 18, but currently the same institution recognizes that this percentage is 8.5%, with notable differences depending on region or country

The report suggests that children with pre-existing conditions such as obesity, chronic lung diseases, cardiovascular, neurological, immune deficiencies, cancer, and chromosomal diseases such as Down syndrome are at higher risk of severe Covid disease, an increased need for intensive care units and a have higher mortality.

You can also read:  Prosecutor takes first step to prosecute Áñez

“Historically, vaccinating children and adolescents against epidemic infections is without a doubt the most important public health measure after supplying the population with drinking water,” the report said.

In Europe, North America, and most of South America, vaccination was ordered between the ages of 12 and 18 with Pfizer / Biontech or CoronaVac. “In Bolivia, it is pertinent and necessary that this age group be vaccinated, both because of the need to protect them from infection with the risk of hospitalization and death, and because of the risk of multisystem inflammatory syndrome and the consequences it entails various organs, and organ systems, “they pointed out.

The report says that any vaccine can have side effects, most are mild and short-lived, and not all people have these reactions.

“In the case of the SARS-CoV-2 vaccine, the common responses seen in adolescents were similar to those seen in adults: mild to moderate injection site pain, fatigue, headache and fever, with remission within 72 hours. Other secondary reactions are isolated and deserve pediatric surveillance, but they do not detract from the utility and utility of their general indication, ”they pointed out.

You can also read:  Parents see their children "stop learning" in times of pandemic

The experts affirmed that this eminently school population should be protected in the event of a full return to face-to-face teaching, a situation which in part already occurs today and which, due to insufficient funds and resources, is more urgently needed in our country to indefinitely extend the virtual modality which, due to the same socio-economic conditions of our population, the application of which was rather irregular and poor.

All of this without compromising the need to restore interaction and social relationships with children and adolescents as soon as possible in order to maintain their mental and emotional health, they pointed out.

LEAVE A REPLY

Please enter your comment!
Please enter your name here